Homarylamine (INN;[1] also known as 3,4-methylenedioxy-N-methylphenethylamine and MDMPEA) is an antitussive (anti-cough) drug[2] which was patented in 1956 by Merck & Co.,[3] but has never been used medically as such.

It is the N-methylated analog of methylenedioxyphenethylamine (MDPEA).

It is a schedule I drug in the USA as a positional isomer of MDA.

Reaction of homoarylamine with formaldehyde gives hydrastinine.

This drug article relating to the respiratory system is a stub.